{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:56:15Z","timestamp":1792828575447,"version":"4.5.0"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s12022-022-09742-0","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T21:46:25Z","timestamp":1668807985000},"page":"57-78","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Spectrum of Familial Pituitary Neuroendocrine Tumors"],"prefix":"10.1007","volume":"34","author":[{"given":"Eleni","family":"Armeni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"key":"9742_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"Asa SL, Mete O, Perry A, Osamura RY (2022) Overview of the 2022 WHO Classification of Pituitary Tumors. Endocr Pathol 33:6\u201326. https:\/\/doi.org\/10.1007\/s12022-022-09703-7","journal-title":"Endocr Pathol"},{"key":"9742_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/oxfordjournals.epirev.a036232","volume":"3","author":"EB Gold","year":"1981","unstructured":"Gold EB (1981) Epidemiology of pituitary adenomas. Epidemiol Rev 3:163\u2013183. https:\/\/doi.org\/10.1093\/oxfordjournals.epirev.a036232","journal-title":"Epidemiol Rev"},{"key":"9742_CR3","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/cncr.20412","volume":"101","author":"S Ezzat","year":"2004","unstructured":"Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE (2004) The prevalence of pituitary adenomas: a systematic review. Cancer 101:613\u2013619. https:\/\/doi.org\/10.1002\/cncr.20412","journal-title":"Cancer"},{"key":"9742_CR4","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1210\/jc.2006-1668","volume":"91","author":"AF Daly","year":"2006","unstructured":"Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A (2006) High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 91:4769\u20134775. https:\/\/doi.org\/10.1210\/jc.2006-1668","journal-title":"J Clin Endocrinol Metab"},{"key":"9742_CR5","first-page":"2172","volume":"5","author":"E Fontana","year":"2009","unstructured":"Fontana E, Gaillard R (2009) [Epidemiology of pituitary adenoma: results of the first Swiss study]. Rev Med Suisse 5:2172\u20132174","journal-title":"Rev Med Suisse"},{"key":"9742_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","volume":"72","author":"A Fernandez","year":"2010","unstructured":"Fernandez A, Karavitaki N, Wass JAH (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 72:377\u2013382. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03667.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9742_CR7","doi-asserted-by":"crossref","unstructured":"Daly AF, Beckers A (2017) Chapter 21 - Genetics of Pituitary Tumor Syndromes. In: Melmed SBT-TP (Fourth E (ed). Academic Press, pp 619\u2013630","DOI":"10.1016\/B978-0-12-804169-7.00021-0"},{"key":"9742_CR8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.beem.2009.05.008","volume":"23","author":"AF Daly","year":"2009","unstructured":"Daly AF, Tichomirowa MA, Beckers A (2009) The epidemiology and genetics of pituitary adenomas. Best Pract Res Clin Endocrinol Metab 23:543\u2013554. https:\/\/doi.org\/10.1016\/j.beem.2009.05.008","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"9742_CR9","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1210\/jc.2005-2671","volume":"91","author":"AF Daly","year":"2006","unstructured":"Daly AF, Jaffrain-Rea M-L, Ciccarelli A, Valdes-Socin H, Rohmer V, Tamburrano G, Borson-Chazot C, Estour B, Ciccarelli E, Brue T, Ferolla P, Emy P, Colao A, De Menis E, Lecomte P, Penfornis F, Delemer B, Bertherat J, W\u00e9meau JL, De Herder W, Archambeaud F, Stevenaert A, Calender A, Murat A, Cavagnini F, Beckers A (2006) Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab 91:3316\u20133323. https:\/\/doi.org\/10.1210\/jc.2005-2671","journal-title":"J Clin Endocrinol Metab"},{"key":"9742_CR10","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-z","volume":"75","author":"European Chromosome 16 Tuberous Sclerosis Consortium","year":"1993","unstructured":"European Chromosome 16 Tuberous Sclerosis Consortium (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75:1305\u20131315. https:\/\/doi.org\/10.1016\/0092-8674(93)90618-z","journal-title":"Cell"},{"key":"9742_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/ng0992-37","volume":"2","author":"RS Kandt","year":"1992","unstructured":"Kandt RS, Haines JL, Smith M, Northrup H, Gardner RJ, Short MP, Dumars K, Roach ES, Steingold S, Wall S (1992) Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet 2:37\u201341. https:\/\/doi.org\/10.1038\/ng0992-37","journal-title":"Nat Genet"},{"key":"9742_CR12","doi-asserted-by":"publisher","first-page":"E531","DOI":"10.1210\/jc.2014-3399","volume":"100","author":"J D\u00e9nes","year":"2015","unstructured":"D\u00e9nes J, Swords F, Rattenberry E, Stals K, Owens M, Cranston T, Xekouki P, Moran L, Kumar A, Wassif C, Fersht N, Baldeweg SE, Morris D, Lightman S, Agha A, Rees A, Grieve J, Powell M, Boguszewski CL, Dutta P, Thakker RV, Srirangalingam U, Thompson CJ, Druce M, Higham C, Davis J, Eeles R, Stevenson M, O\u2019Sullivan B, Taniere P, Skordilis K, Gabrovska P, Barlier A, Webb SM, Aulinas A, Drake WM, Bevan JS, Preda C, Dalantaeva N, Ribeiro-Oliveira AJ, Garcia IT, Yordanova G, Iotova V, Evanson J, Grossman AB, Trouillas J, Ellard S, Stratakis CA, Maher ER, Roncaroli F, Korbonits M (2015) Heterogeneous genetic background of the association of pheochromocytoma\/paraganglioma and pituitary adenoma: results from a large patient cohort. J Clin Endocrinol Metab 100:E531-541. https:\/\/doi.org\/10.1210\/jc.2014-3399","journal-title":"J Clin Endocrinol Metab"},{"key":"9742_CR13","doi-asserted-by":"publisher","first-page":"C33","DOI":"10.1530\/ERC-12-0118","volume":"19","author":"P Xekouki","year":"2012","unstructured":"Xekouki P, Stratakis CA (2012) Succinate dehydrogenase (SDHx) mutations in pituitary tumors: could this be a new role for mitochondrial complex II and\/or Krebs cycle defects? Endocr Relat Cancer 19:C33-40. https:\/\/doi.org\/10.1530\/ERC-12-0118","journal-title":"Endocr Relat Cancer"},{"key":"9742_CR14","doi-asserted-by":"publisher","first-page":"T91","DOI":"10.1530\/ERC-15-0268","volume":"22","author":"DE Benn","year":"2015","unstructured":"Benn DE, Robinson BG, Clifton-Bligh RJ (2015) 15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1-5. Endocr Relat Cancer 22:T91-103. https:\/\/doi.org\/10.1530\/ERC-15-0268","journal-title":"Endocr Relat Cancer"},{"key":"9742_CR15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1055\/a-0661-0341","volume":"51","author":"P Xekouki","year":"2019","unstructured":"Xekouki P, Brennand A, Whitelaw B, Pacak K, Stratakis CA (2019) The 3PAs: An Update on the Association of Pheochromocytomas, Paragangliomas, and Pituitary Tumors. Horm Metab Res Horm Stoffwechselforschung Horm Metab 51:419\u2013436. https:\/\/doi.org\/10.1055\/a-0661-0341","journal-title":"Horm Metab Res Horm Stoffwechselforschung Horm Metab"},{"key":"9742_CR16","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1055\/a-1143-5930","volume":"52","author":"V Vasilev","year":"2020","unstructured":"Vasilev V, Daly AF, Zacharieva S, Beckers A (2020) Clinical and Molecular Update on Genetic Causes of Pituitary Adenomas. Horm Metab Res Horm Stoffwechselforschung Horm Metab 52:553\u2013561. https:\/\/doi.org\/10.1055\/a-1143-5930","journal-title":"Horm Metab Res Horm Stoffwechselforschung Horm Metab"},{"key":"9742_CR17","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1210\/endrev\/bnaa006","volume":"41","author":"V Srirangam Nadhamuni","year":"2020","unstructured":"Srirangam Nadhamuni V, Korbonits M (2020) Novel Insights into Pituitary Tumorigenesis: Genetic and Epigenetic Mechanisms. Endocr Rev 41:821\u2013846. https:\/\/doi.org\/10.1210\/endrev\/bnaa006","journal-title":"Endocr Rev"},{"key":"9742_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000505498","volume":"36","author":"J Manoharan","year":"2020","unstructured":"Manoharan J, Bollmann C, Kann PH, Di Fazio P, Bartsch DK, Albers MB (2020) Gender Differences in Multiple Endocrine Neoplasia Type 1: Implications for Screening? Visc Med 36:3\u20139. https:\/\/doi.org\/10.1159\/000505498","journal-title":"Visc Med"},{"key":"9742_CR19","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1126\/science.1126100","volume":"312","author":"O Vierimaa","year":"2006","unstructured":"Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TML, Salmela PI, Paschke R, G\u00fcndogdu S, De Menis E, M\u00e4kinen MJ, Launonen V, Karhu A, Aaltonen LA (2006) Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312:1228\u20131230. https:\/\/doi.org\/10.1126\/science.1126100","journal-title":"Science"},{"key":"9742_CR20","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1210\/jc.2006-2513","volume":"92","author":"AF Daly","year":"2007","unstructured":"Daly AF, Vanbellinghen J-F, Khoo SK, Jaffrain-Rea M-L, Naves LA, Guitelman MA, Murat A, Emy P, Gimenez-Roqueplo A-P, Tamburrano G, Raverot G, Barlier A, De Herder W, Penfornis A, Ciccarelli E, Estour B, Lecomte P, Gatta B, Chabre O, Sabat\u00e9 MI, Bertagna X, Garcia Basavilbaso N, Stalldecker G, Colao A, Ferolla P, W\u00e9meau J-L, Caron P, Sadoul J-L, Oneto A, Archambeaud F, Calender A, Sinilnikova O, Monta\u00f1ana CF, Cavagnini F, Hana V, Solano A, Delettieres D, Luccio-Camelo DC, Basso A, Rohmer V, Brue T, Bours V, Teh BT, Beckers A (2007) Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab 92:1891\u20131896. https:\/\/doi.org\/10.1210\/jc.2006-2513","journal-title":"J Clin Endocrinol Metab"},{"key":"9742_CR21","doi-asserted-by":"publisher","first-page":"T77","DOI":"10.1530\/ERC-20-0015","volume":"27","author":"V Vasilev","year":"2020","unstructured":"Vasilev V, Daly AF, Trivellin G, Stratakis CA, Zacharieva S, Beckers A (2020) HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The roles of AIP and GPR101 in familial isolated pituitary adenomas (FIPA). Endocr Relat Cancer 27:T77\u2013T86. https:\/\/doi.org\/10.1530\/ERC-20-0015","journal-title":"Endocr Relat Cancer"},{"key":"9742_CR22","doi-asserted-by":"publisher","first-page":"E1242","DOI":"10.1210\/jc.2015-1869","volume":"100","author":"LC Hern\u00e1ndez-Ram\u00edrez","year":"2015","unstructured":"Hern\u00e1ndez-Ram\u00edrez LC, Gabrovska P, D\u00e9nes J, Stals K, Trivellin G, Tilley D, Ferrau F, Evanson J, Ellard S, Grossman AB, Roncaroli F, Gadelha MR, Korbonits M (2015) Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers. J Clin Endocrinol Metab 100:E1242-54. https:\/\/doi.org\/10.1210\/jc.2015-1869","journal-title":"J Clin Endocrinol Metab"},{"key":"9742_CR23","doi-asserted-by":"publisher","first-page":"E2789","DOI":"10.1210\/jc.2014-2094","volume":"99","author":"C Sch\u00f6fl","year":"2014","unstructured":"Sch\u00f6fl C, Honegger J, Droste M, Grussendorf M, Finke R, Pl\u00f6ckinger U, Berg C, Willenberg HS, Lammert A, Klingm\u00fcller D, Jaursch-Hancke C, T\u00f6njes A, Schneidewind S, Flitsch J, Bullmann C, Dimopoulou C, Stalla G, Mayr B, Hoeppner W, Schopohl J (2014) Frequency of AIP gene mutations in young patients with acromegaly: a registry-based study. J Clin Endocrinol Metab 99:E2789-93. https:\/\/doi.org\/10.1210\/jc.2014-2094","journal-title":"J Clin Endocrinol Metab"},{"key":"9742_CR24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1365-2265.2012.04445.x","volume":"77","author":"M Korbonits","year":"2012","unstructured":"Korbonits M, Storr H, Kumar A V (2012) Familial pituitary adenomas - who should be tested for AIP mutations? Clin Endocrinol (Oxf) 77:351\u2013356. https:\/\/doi.org\/10.1111\/j.1365-2265.2012.04445.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9742_CR25","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s12022-022-09723-3","volume":"33","author":"R Lu","year":"2022","unstructured":"Lu R, Pu C, Pekmeczi M, Perry A (2022) Immature PIT1-Lineage Pituitary Neuroendocrine Tumor: a 17-Year-Old Male with Pathogenic AIP Mutation. Endocr Pathol 33:414\u2013416. https:\/\/doi.org\/10.1007\/s12022-022-09723-3","journal-title":"Endocr Pathol"},{"key":"9742_CR26","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/aps.2014.159","volume":"36","author":"C Gonzalez","year":"2015","unstructured":"Gonzalez C, Rosas-Hernandez H, Jurado-Manzano B, Ramirez-Lee MA, Salazar-Garcia S, Martinez-Cuevas PP, Velarde-Salcedo AJ, Morales-Loredo H, Espinosa-Tanguma R, Ali SF, Rubio R (2015) The prolactin family hormones regulate vascular tone through NO and prostacyclin production in isolated rat aortic rings. Acta Pharmacol Sin 36:572\u2013586. https:\/\/doi.org\/10.1038\/aps.2014.159","journal-title":"Acta Pharmacol Sin"},{"key":"9742_CR27","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1530\/EJE-11-0304","volume":"165","author":"MA Tichomirowa","year":"2011","unstructured":"Tichomirowa MA, Barlier A, Daly AF, Jaffrain-Rea M-L, Ronchi C, Yaneva M, Urban JD, Petrossians P, Elenkova A, Tabarin A, Desailloud R, Maiter D, Sch\u00fcrmeyer T, Cozzi R, Theodoropoulou M, Sievers C, Bernabeu I, Naves LA, Chabre O, Monta\u00f1ana CF, Hana V, Halaby G, Delemer B, Aizp\u00fan JIL, Sonnet E, Long\u00e1s AF, Hagelstein M-T, Caron P, Stalla GK, Bours V, Zacharieva S, Spada A, Brue T, Beckers A (2011) High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. Eur J Endocrinol 165:509\u2013515. https:\/\/doi.org\/10.1530\/EJE-11-0304","journal-title":"Eur J Endocrinol"},{"key":"9742_CR28","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1210\/jc.2016-1307","volume":"101","author":"LC Hern\u00e1ndez-Ram\u00edrez","year":"2016","unstructured":"Hern\u00e1ndez-Ram\u00edrez LC, Martucci F, Morgan RML, Trivellin G, Tilley D, Ramos-Guajardo N, Iacovazzo D, D\u2019Acquisto F, Prodromou C, Korbonits M (2016) Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With Missense AIP Mutations. J Clin Endocrinol Metab 101:3144\u20133154. https:\/\/doi.org\/10.1210\/jc.2016-1307","journal-title":"J Clin Endocrinol Metab"},{"key":"9742_CR29","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/humu.21292","volume":"31","author":"S Igreja","year":"2010","unstructured":"Igreja S, Chahal HS, King P, Bolger GB, Srirangalingam U, Guasti L, Chapple JP, Trivellin G, Gueorguiev M, Guegan K, Stals K, Khoo B, Kumar A V, Ellard S, Grossman AB, Korbonits M (2010) Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families. Hum Mutat 31:950\u2013960. https:\/\/doi.org\/10.1002\/humu.21292","journal-title":"Hum Mutat"},{"key":"9742_CR30","doi-asserted-by":"publisher","first-page":"E373","DOI":"10.1210\/jc.2009-2556","volume":"95","author":"AF Daly","year":"2010","unstructured":"Daly AF, Tichomirowa MA, Petrossians P, Heli\u00f6vaara E, Jaffrain-Rea M-L, Barlier A, Naves LA, Ebeling T, Karhu A, Raappana A, Cazabat L, De Menis E, Monta\u00f1ana CF, Raverot G, Weil RJ, Sane T, Maiter D, Neggers S, Yaneva M, Tabarin A, Verrua E, Eloranta E, Murat A, Vierimaa O, Salmela PI, Emy P, Toledo RA, Sabat\u00e9 MI, Villa C, Popelier M, Salvatori R, Jennings J, Long\u00e1s AF, Labarta Aizp\u00fan JI, Georgitsi M, Paschke R, Ronchi C, Valimaki M, Saloranta C, De Herder W, Cozzi R, Guitelman M, Magri F, Lagonigro MS, Halaby G, Corman V, Hagelstein M-T, Vanbellinghen J-F, Barra GB, Gimenez-Roqueplo A-P, Cameron FJ, Borson-Chazot F, Holdaway I, Toledo SPA, Stalla GK, Spada A, Zacharieva S, Bertherat J, Brue T, Bours V, Chanson P, Aaltonen LA, Beckers A (2010) Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J Clin Endocrinol Metab 95:E373-83. https:\/\/doi.org\/10.1210\/jc.2009-2556","journal-title":"J Clin Endocrinol Metab"},{"key":"9742_CR31","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1530\/EJE-14-0426","volume":"171","author":"V Preda","year":"2014","unstructured":"Preda V, Korbonits M, Cudlip S, Karavitaki N, Grossman AB (2014) Low rate of germline AIP mutations in patients with apparently sporadic pituitary adenomas before the age of 40: a single-centre adult cohort. Eur J Endocrinol 171:659\u2013666. https:\/\/doi.org\/10.1530\/EJE-14-0426","journal-title":"Eur J Endocrinol"},{"key":"9742_CR32","doi-asserted-by":"publisher","first-page":"e2247","DOI":"10.1210\/clinem\/dgaa040","volume":"105","author":"P Marques","year":"2020","unstructured":"Marques P, Caimari F, Hern\u00e1ndez-Ram\u00edrez LC, Collier D, Iacovazzo D, Ronaldson A, Magid K, Lim CT, Stals K, Ellard S, Grossman AB, Korbonits M (2020) Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors. J Clin Endocrinol Metab 105:e2247-2260. https:\/\/doi.org\/10.1210\/clinem\/dgaa040","journal-title":"J Clin Endocrinol Metab"},{"key":"9742_CR33","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1038\/s41379-021-00820-y","volume":"34","author":"SL Asa","year":"2021","unstructured":"Asa SL, Mete O, Cusimano MD, McCutcheon IE, Perry A, Yamada S, Nishioka H, Casar-Borota O, Uccella S, La Rosa S, Grossman AB, Ezzat S (2021) Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification. Mod Pathol Off J U S Can Acad Pathol Inc 34:1634\u20131650. https:\/\/doi.org\/10.1038\/s41379-021-00820-y","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"9742_CR34","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1530\/EC-19-0027","volume":"8","author":"AF Daly","year":"2019","unstructured":"Daly AF, Cano DA, Venegas-Moreno E, Petrossians P, Dios E, Castermans E, Flores-Mart\u00ednez A, Bours V, Beckers A, Soto-Moreno A (2019) AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center. Endocr Connect 8:338\u2013348. https:\/\/doi.org\/10.1530\/EC-19-0027","journal-title":"Endocr Connect"},{"key":"9742_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000322787","volume":"94","author":"Kasuki Jomori","year":"2011","unstructured":"Kasuki Jomori de Pinho L, Vieira Neto L, Armondi Wildemberg LE, Gasparetto EL, Marcondes J, de Almeida Nunes B, Takiya CM, Gadelha MR (2011) Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53. Neuroendocrinology 94:39\u201348. https:\/\/doi.org\/10.1159\/000322787","journal-title":"Neuroendocrinology"},{"key":"9742_CR36","doi-asserted-by":"publisher","first-page":"L25","DOI":"10.1530\/ERC-12-0020","volume":"19","author":"L Kasuki","year":"2012","unstructured":"Kasuki L, Vieira Neto L, Wildemberg LEA, Colli LM, de Castro M, Takiya CM, Gadelha MR (2012) AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression. Endocr Relat Cancer 19:L25-29. https:\/\/doi.org\/10.1530\/ERC-12-0020","journal-title":"Endocr Relat Cancer"},{"key":"9742_CR37","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12902-021-00850-2","volume":"21","author":"M Dehghani","year":"2021","unstructured":"Dehghani M, Davoodi Z, Bidari F, Moghaddam AM, Khalili D, Bahrami-Motlagh H, Jamali E, Alamdari S, Hosseinpanah F, Hedayati M, Valizadeh M (2021) Association of different pathologic subtypes of growth hormone producing pituitary adenoma and remission in acromegaly patients: a retrospective cohort study. BMC Endocr Disord 21:186. https:\/\/doi.org\/10.1186\/s12902-021-00850-2","journal-title":"BMC Endocr Disord"},{"key":"9742_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112254","author":"SL Asa","year":"2021","unstructured":"Asa SL, Ezzat S (2021) An Update on Pituitary Neuroendocrine Tumors Leading to Acromegaly and Gigantism. J Clin Med 10:. https:\/\/doi.org\/10.3390\/jcm10112254","journal-title":"J Clin Med"},{"key":"9742_CR39","unstructured":"Mete, Ozgur, Perry, Arie, Lopes MBS, Yamada S, Ezzat S (2022) Somatotroph PitNET\/adenoma. In: Endocrine and Neuroendocirne tumours, 5th ed"},{"key":"9742_CR40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mce.2010.05.001","volume":"326","author":"Z Ozfirat","year":"2010","unstructured":"Ozfirat Z, Korbonits M (2010) AIP gene and familial isolated pituitary adenomas. Mol Cell Endocrinol 326:71\u201379. https:\/\/doi.org\/10.1016\/j.mce.2010.05.001","journal-title":"Mol Cell Endocrinol"},{"key":"9742_CR41","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1530\/ERC-17-0112","volume":"24","author":"R Formosa","year":"2017","unstructured":"Formosa R, Borg J, Vassallo J (2017) Aryl hydrocarbon receptor (AHR) is a potential tumour suppressor in pituitary adenomas. Endocr Relat Cancer 24:445\u2013457. https:\/\/doi.org\/10.1530\/ERC-17-0112","journal-title":"Endocr Relat Cancer"},{"key":"9742_CR42","doi-asserted-by":"publisher","first-page":"41317","DOI":"10.1074\/jbc.M007765200","volume":"275","author":"A Kazlauskas","year":"2000","unstructured":"Kazlauskas A, Poellinger L, Pongratz I (2000) The immunophilin-like protein XAP2 regulates ubiquitination and subcellular localization of the dioxin receptor. J Biol Chem 275:41317\u201341324. https:\/\/doi.org\/10.1074\/jbc.M007765200","journal-title":"J Biol Chem"},{"key":"9742_CR43","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/oxfordjournals.jbchem.a003289","volume":"132","author":"S Shimba","year":"2002","unstructured":"Shimba S, Komiyama K, Moro I, Tezuka M (2002) Overexpression of the Aryl Hydrocarbon Receptor (AhR) Accelerates the Cell Proliferation of A549 Cells1. J Biochem (Tokyo) 132:795\u2013802. https:\/\/doi.org\/10.1093\/oxfordjournals.jbchem.a003289","journal-title":"J Biochem (Tokyo)"},{"key":"9742_CR44","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1074\/jbc.275.4.2943","volume":"275","author":"A Puga","year":"2000","unstructured":"Puga A, Barnes SJ, Dalton TP, Chang C y, Knudsen ES, Maier MA (2000) Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. J Biol Chem 275:2943\u20132950. https:\/\/doi.org\/10.1074\/jbc.275.4.2943","journal-title":"J Biol Chem"},{"key":"9742_CR45","doi-asserted-by":"publisher","first-page":"29013","DOI":"10.1074\/jbc.M404315200","volume":"279","author":"JL Marlowe","year":"2004","unstructured":"Marlowe JL, Knudsen ES, Schwemberger S, Puga A (2004) The aryl hydrocarbon receptor displaces p300 from E2F-dependent promoters and represses S phase-specific gene expression. J Biol Chem 279:29013\u201329022. https:\/\/doi.org\/10.1074\/jbc.M404315200","journal-title":"J Biol Chem"},{"key":"9742_CR46","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1101\/gad.13.13.1742","volume":"13","author":"SK Kolluri","year":"1999","unstructured":"Kolluri SK, Weiss C, Koff A, G\u00f6ttlicher M (1999) p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev 13:1742\u20131753. https:\/\/doi.org\/10.1101\/gad.13.13.1742","journal-title":"Genes Dev"},{"key":"9742_CR47","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/jcp.24583","volume":"229","author":"Y-H Hsu","year":"2014","unstructured":"Hsu Y-H, Chang C-C, Yang N-J, Lee Y-H, Juan S-H (2014) RhoA-mediated inhibition of vascular endothelial cell mobility: positive feedback through reduced cytosolic p21 and p27. J Cell Physiol 229:1455\u20131465. https:\/\/doi.org\/10.1002\/jcp.24583","journal-title":"J Cell Physiol"},{"key":"9742_CR48","doi-asserted-by":"publisher","first-page":"6354","DOI":"10.1038\/s41388-021-02009-8","volume":"40","author":"AR Garcia-Rendueles","year":"2021","unstructured":"Garcia-Rendueles AR, Chenlo M, Oroz-Gonjar F, Solomou A, Mistry A, Barry S, Gaston-Massuet C, Garcia-Lavandeira M, Perez-Romero S, Suarez-Fari\u00f1a M, Pradilla-Dieste A, Dieguez C, Mehlen P, Korbonits M, Alvarez CV (2021) RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas. Oncogene 40:6354\u20136368. https:\/\/doi.org\/10.1038\/s41388-021-02009-8","journal-title":"Oncogene"},{"key":"9742_CR49","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1093\/hmg\/ddy166","volume":"27","author":"MH Schernthaner-Reiter","year":"2018","unstructured":"Schernthaner-Reiter MH, Trivellin G, Stratakis CA (2018) Interaction of AIP with protein kinase A (cAMP-dependent protein kinase). Hum Mol Genet 27:2604\u20132613. https:\/\/doi.org\/10.1093\/hmg\/ddy166","journal-title":"Hum Mol Genet"},{"key":"9742_CR50","doi-asserted-by":"publisher","unstructured":"Hern\u00e1ndez-Ram\u00edrez LC, Morgan RML, Barry S, D\u2019Acquisto F, Prodromou C, Korbonits M (2018) Multi-chaperone function modulation and association with cytoskeletal proteins are key features of the function of AIP in the pituitary gland. Oncotarget 9:9177\u20139198. https:\/\/doi.org\/10.18632\/oncotarget.24183","DOI":"10.18632\/oncotarget.24183"},{"key":"9742_CR51","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1056\/NEJMoa1408028","volume":"371","author":"G Trivellin","year":"2014","unstructured":"Trivellin G, Daly AF, Faucz FR, Yuan B, Rostomyan L, Larco DO, Schernthaner-Reiter MH, Szarek E, Leal LF, Caberg J-H, Castermans E, Villa C, Dimopoulos A, Chittiboina P, Xekouki P, Shah N, Metzger D, Lysy PA, Ferrante E, Strebkova N, Mazerkina N, Zatelli MC, Lodish M, Horvath A, de Alexandre RB, Manning AD, Levy I, Keil MF, Sierra M de la L, Palmeira L, Coppieters W, Georges M, Naves LA, Jamar M, Bours V, Wu TJ, Choong CS, Bertherat J, Chanson P, Kamenick\u00fd P, Farrell WE, Barlier A, Quezado M, Bjelobaba I, Stojilkovic SS, Wess J, Costanzi S, Liu P, Lupski JR, Beckers A, Stratakis CA (2014) Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. N Engl J Med 371:2363\u20132374. https:\/\/doi.org\/10.1056\/NEJMoa1408028","journal-title":"N Engl J Med"},{"key":"9742_CR52","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1210\/jc.2015-4366","volume":"101","author":"C Rodd","year":"2016","unstructured":"Rodd C, Millette M, Iacovazzo D, Stiles CE, Barry S, Evanson J, Albrecht S, Caswell R, Bunce B, Jose S, Trouillas J, Roncaroli F, Sampson J, Ellard S, Korbonits M (2016) Somatic GPR101 Duplication Causing X-Linked Acrogigantism (XLAG)\u2014Diagnosis and Management. J Clin Endocrinol Metab 101:1927\u20131930. https:\/\/doi.org\/10.1210\/jc.2015-4366","journal-title":"J Clin Endocrinol Metab"},{"key":"9742_CR53","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1530\/ERC-16-0082","volume":"23","author":"AF Daly","year":"2016","unstructured":"Daly AF, Yuan B, Fina F, Caberg J-H, Trivellin G, Rostomyan L, de Herder WW, Naves LA, Metzger D, Cuny T, Rabl W, Shah N, Jaffrain-Rea M-L, Zatelli MC, Faucz FR, Castermans E, Nanni-Metellus I, Lodish M, Muhammad A, Palmeira L, Potorac I, Mantovani G, Neggers SJ, Klein M, Barlier A, Liu P, Ouafik L, Bours V, Lupski JR, Stratakis CA, Beckers A (2016) Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects. Endocr Relat Cancer 23:221\u2013233. https:\/\/doi.org\/10.1530\/ERC-16-0082","journal-title":"Endocr Relat Cancer"},{"key":"9742_CR54","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12902-022-01058-8","volume":"22","author":"X-D Bao","year":"2022","unstructured":"Bao X-D, Lu L, Zhu H-J, Yao Y, Feng M, Wang R-Z, Zhai X, Fu Y, Gong F-Y, Lu Z-L (2022) Concurrent mutations of germline GPR101 and somatic USP8 in a pediatric giant pituitary ACTH adenoma: a case report. BMC Endocr Disord 22:152. https:\/\/doi.org\/10.1186\/s12902-022-01058-8","journal-title":"BMC Endocr Disord"},{"key":"9742_CR55","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/17446651.2020.1749048","volume":"15","author":"LC Hern\u00e1ndez-Ram\u00edrez","year":"2020","unstructured":"Hern\u00e1ndez-Ram\u00edrez LC (2020) Potential markers of disease behavior in acromegaly and gigantism. Expert Rev Endocrinol Metab 15:171\u2013183. https:\/\/doi.org\/10.1080\/17446651.2020.1749048","journal-title":"Expert Rev Endocrinol Metab"},{"key":"9742_CR56","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1530\/ERC-15-0038","volume":"22","author":"A Beckers","year":"2015","unstructured":"Beckers A, Lodish MB, Trivellin G, Rostomyan L, Lee M, Faucz FR, Yuan B, Choong CS, Caberg J-H, Verrua E, Naves LA, Cheetham TD, Young J, Lysy PA, Petrossians P, Cotterill A, Shah NS, Metzger D, Castermans E, Ambrosio MR, Villa C, Strebkova N, Mazerkina N, Gaillard S, Barra GB, Casulari LA, Neggers SJ, Salvatori R, Jaffrain-Rea M-L, Zacharin M, Santamaria BL, Zacharieva S, Lim EM, Mantovani G, Zatelli MC, Collins MT, Bonneville J-F, Quezado M, Chittiboina P, Oldfield EH, Bours V, Liu P, W de Herder W, Pellegata N, Lupski JR, Daly AF, Stratakis CA (2015) X-linked acrogigantism syndrome: clinical profile and therapeutic responses. Endocr Relat Cancer 22:353\u2013367. https:\/\/doi.org\/10.1530\/ERC-15-0038","journal-title":"Endocr Relat Cancer"},{"key":"9742_CR57","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40478-016-0328-1","volume":"4","author":"D Iacovazzo","year":"2016","unstructured":"Iacovazzo D, Caswell R, Bunce B, Jose S, Yuan B, Hern\u00e1ndez-Ram\u00edrez LC, Kapur S, Caimari F, Evanson J, Ferra\u00f9 F, Dang MN, Gabrovska P, Larkin SJ, Ansorge O, Rodd C, Vance ML, Ram\u00edrez-Renteria C, Mercado M, Goldstone AP, Buchfelder M, Burren CP, Gurlek A, Dutta P, Choong CS, Cheetham T, Trivellin G, Stratakis CA, Lopes M-B, Grossman AB, Trouillas J, Lupski JR, Ellard S, Sampson JR, Roncaroli F, Korbonits M (2016) Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study. Acta Neuropathol Commun 4:56. https:\/\/doi.org\/10.1186\/s40478-016-0328-1","journal-title":"Acta Neuropathol Commun"},{"key":"9742_CR58","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.beem.2018.02.004","volume":"32","author":"G Trivellin","year":"2018","unstructured":"Trivellin G, Hern\u00e1ndez-Ram\u00edrez LC, Swan J, Stratakis CA (2018) An orphan G-protein-coupled receptor causes human gigantism and\/or acromegaly: Molecular biology and clinical correlations. Best Pract Res Clin Endocrinol Metab 32:125\u2013140. https:\/\/doi.org\/10.1016\/j.beem.2018.02.004","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"9742_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2006.02.123","volume":"1087","author":"B Bates","year":"2006","unstructured":"Bates B, Zhang L, Nawoschik S, Kodangattil S, Tseng E, Kopsco D, Kramer A, Shan Q, Taylor N, Johnson J, Sun Y, Chen HM, Blatcher M, Paulsen JE, Pausch MH (2006) Characterization of Gpr101 expression and G-protein coupling selectivity. Brain Res 1087:1\u201314. https:\/\/doi.org\/10.1016\/j.brainres.2006.02.123","journal-title":"Brain Res"},{"key":"9742_CR60","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1530\/JME-16-0045","volume":"57","author":"G Trivellin","year":"2016","unstructured":"Trivellin G, Bjelobaba I, Daly AF, Larco DO, Palmeira L, Faucz FR, Thiry A, Leal LF, Rostomyan L, Quezado M, Schernthaner-Reiter MH, Janjic MM, Villa C, Wu TJ, Stojilkovic SS, Beckers A, Feldman B, Stratakis CA (2016) Characterization of GPR101 transcript structure and expression patterns. J Mol Endocrinol 57:97\u2013111. https:\/\/doi.org\/10.1530\/JME-16-0045","journal-title":"J Mol Endocrinol"},{"key":"9742_CR61","doi-asserted-by":"publisher","first-page":"4752","DOI":"10.1038\/s41467-020-18500-x","volume":"11","author":"D Abboud","year":"2020","unstructured":"Abboud D, Daly AF, Dupuis N, Bahri MA, Inoue A, Chevign\u00e9 A, Ectors F, Plenevaux A, Pirotte B, Beckers A, Hanson J (2020) GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of G(s) and G(q\/11). Nat Commun 11:4752. https:\/\/doi.org\/10.1038\/s41467-020-18500-x","journal-title":"Nat Commun"},{"key":"9742_CR62","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12916-016-0708-1","volume":"14","author":"JM de Laat","year":"2016","unstructured":"de Laat JM, van der Luijt RB, Pieterman CRC, Oostveen MP, Hermus AR, Dekkers OM, de Herder WW, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, Vriens MR, Valk GD (2016) MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients. BMC Med 14:182. https:\/\/doi.org\/10.1186\/s12916-016-0708-1","journal-title":"BMC Med"},{"key":"9742_CR63","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","volume":"386","author":"RV Thakker","year":"2014","unstructured":"Thakker R V (2014) Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4). Mol Cell Endocrinol 386:2\u201315. https:\/\/doi.org\/10.1016\/j.mce.2013.08.002","journal-title":"Mol Cell Endocrinol"},{"key":"9742_CR64","doi-asserted-by":"publisher","first-page":"15558","DOI":"10.1073\/pnas.0603877103","volume":"103","author":"NS Pellegata","year":"2006","unstructured":"Pellegata NS, Quintanilla-Martinez L, Siggelkow H, Samson E, Bink K, H\u00f6fler H, Fend F, Graw J, Atkinson MJ (2006) Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci U S A 103:15558\u201315563. https:\/\/doi.org\/10.1073\/pnas.0603877103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9742_CR65","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.semcancer.2021.04.011","volume":"79","author":"G Effraimidis","year":"2022","unstructured":"Effraimidis G, Knigge U, Rossing M, Oturai P, Rasmussen \u00c5K, Feldt-Rasmussen U (2022) Multiple endocrine neoplasia type 1 (MEN-1) and neuroendocrine neoplasms (NENs). Semin Cancer Biol 79:141\u2013162. https:\/\/doi.org\/10.1016\/j.semcancer.2021.04.011","journal-title":"Semin Cancer Biol"},{"key":"9742_CR66","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/17446651.2019.1689120","volume":"14","author":"AJJ Shen","year":"2019","unstructured":"Shen AJJ, King J, Scott H, Colman P, Yates CJ (2019) Insights into pituitary tumorigenesis: from Sanger sequencing to next-generation sequencing and beyond. Expert Rev Endocrinol Metab 14:399\u2013418. https:\/\/doi.org\/10.1080\/17446651.2019.1689120","journal-title":"Expert Rev Endocrinol Metab"},{"key":"9742_CR67","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s12022-022-09709-1","volume":"33","author":"LA Erickson","year":"2022","unstructured":"Erickson LA, Mete O, Juhlin CC, Perren A, Gill AJ (2022) Overview of the 2022 WHO Classification of Parathyroid Tumors. Endocr Pathol 33:64\u201389. https:\/\/doi.org\/10.1007\/s12022-022-09709-1","journal-title":"Endocr Pathol"},{"key":"9742_CR68","doi-asserted-by":"publisher","first-page":"R21","DOI":"10.1530\/JOE-18-0446","volume":"240","author":"S Pepe","year":"2019","unstructured":"Pepe S, Korbonits M, Iacovazzo D (2019) Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects. J Endocrinol 240:R21\u2013R45. https:\/\/doi.org\/10.1530\/JOE-18-0446","journal-title":"J Endocrinol"},{"key":"9742_CR69","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1210\/JC.2015-2015","volume":"100","author":"JM de Laat","year":"2015","unstructured":"de Laat JM, Dekkers OM, Pieterman CRC, Kluijfhout WP, Hermus AR, Pereira AM, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, de Herder WW, Valk GD (2015) Long-Term Natural Course of Pituitary Tumors in Patients With MEN1: Results From the DutchMEN1 Study Group (DMSG). J Clin Endocrinol Metab 100:3288\u20133296. https:\/\/doi.org\/10.1210\/JC.2015-2015","journal-title":"J Clin Endocrinol Metab"},{"key":"9742_CR70","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/imj.14394","volume":"49","author":"JE McDonnell","year":"2019","unstructured":"McDonnell JE, Gild ML, Clifton-Bligh RJ, Robinson BG (2019) Multiple endocrine neoplasia: an update. Intern Med J 49:954\u2013961. https:\/\/doi.org\/10.1111\/imj.14394","journal-title":"Intern Med J"},{"key":"9742_CR71","doi-asserted-by":"publisher","first-page":"445","DOI":"10.5603\/EP.a2019.0026","volume":"70","author":"D Rogozi\u0144ski","year":"2019","unstructured":"Rogozi\u0144ski D, Gilis-Januszewska A, Skalniak A, Kluczy\u0144ski \u0141, Pantofli\u0144ski J, Hubalewska-Dydejczyk A (2019) Pituitary tumours in MEN1 syndrome - the new insight into the diagnosis and treatment. Endokrynol Pol 70:445\u2013452. https:\/\/doi.org\/10.5603\/EP.a2019.0026","journal-title":"Endokrynol Pol"},{"key":"9742_CR72","unstructured":"Mete O, Perren A, de Krijger RR, Osamura RY, Gimenez-Roqueplo A-P, Valk GD (2022) Endocrine and Neuroendocrine tumours. In: Multiple endocrine neoplasia type 1"},{"key":"9742_CR73","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/PAS.0b013e31815ade45","volume":"32","author":"J Trouillas","year":"2008","unstructured":"Trouillas J, Labat-Moleur F, Sturm N, Kujas M, Heymann M-F, Figarella-Branger D, Patey M, Mazucca M, Decullier E, Verg\u00e8s B, Chabre O, Calender A (2008) Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients. Am J Surg Pathol 32:534\u2013543. https:\/\/doi.org\/10.1097\/PAS.0b013e31815ade45","journal-title":"Am J Surg Pathol"},{"key":"9742_CR74","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/modpathol.2015.151","volume":"29","author":"O Mete","year":"2016","unstructured":"Mete O, Gomez-Hernandez K, Kucharczyk W, Ridout R, Zadeh G, Gentili F, Ezzat S, Asa SL (2016) Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas. Mod Pathol Off J U S Can Acad Pathol Inc 29:131\u2013142. https:\/\/doi.org\/10.1038\/modpathol.2015.151","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"9742_CR75","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/s0092-8674(00)80967-8","volume":"96","author":"SK Agarwal","year":"1999","unstructured":"Agarwal SK, Guru SC, Heppner C, Erdos MR, Collins RM, Park SY, Saggar S, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ, Burns AL (1999) Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96:143\u2013152. https:\/\/doi.org\/10.1016\/s0092-8674(00)80967-8","journal-title":"Cell"},{"key":"9742_CR76","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.mce.2010.04.011","volume":"326","author":"K Balogh","year":"2010","unstructured":"Balogh K, Pat\u00f3cs A, Hunyady L, R\u00e1cz K (2010) Menin dynamics and functional insight: take your partners. Mol Cell Endocrinol 326:80\u201384. https:\/\/doi.org\/10.1016\/j.mce.2010.04.011","journal-title":"Mol Cell Endocrinol"},{"key":"9742_CR77","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s12020-016-0941-6","volume":"55","author":"S Borsari","year":"2017","unstructured":"Borsari S, Pardi E, Pellegata NS, Lee M, Saponaro F, Torregrossa L, Basolo F, Paltrinieri E, Zatelli MC, Materazzi G, Miccoli P, Marcocci C, Cetani F (2017) Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas. Endocrine 55:386\u2013397. https:\/\/doi.org\/10.1007\/s12020-016-0941-6","journal-title":"Endocrine"},{"key":"9742_CR78","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.1073\/pnas.91.12.5291","volume":"91","author":"L Hengst","year":"1994","unstructured":"Hengst L, Dulic V, Slingerland JM, Lees E, Reed SI (1994) A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc Natl Acad Sci U S A 91:5291\u20135295. https:\/\/doi.org\/10.1073\/pnas.91.12.5291","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9742_CR79","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/humu.20605","volume":"29","author":"MC Lemos","year":"2008","unstructured":"Lemos MC, Thakker R V (2008) Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 29:22\u201332. https:\/\/doi.org\/10.1002\/humu.20605","journal-title":"Hum Mutat"},{"key":"9742_CR80","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1365-2265.1996.tb02069.x","volume":"45","author":"DE Flanagan","year":"1996","unstructured":"Flanagan DE, Armitage M, Clein GP, Thakker R V (1996) Prolactinoma presenting in identical twins with multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf) 45:117\u2013120","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9742_CR81","doi-asserted-by":"publisher","first-page":"T195","DOI":"10.1530\/ERC-17-0243","volume":"24","author":"R Alrezk","year":"2017","unstructured":"Alrezk R, Hannah-Shmouni F, Stratakis CA (2017) MEN4 and CDKN1B mutations: the latest of the MEN syndromes. Endocr Relat Cancer 24:T195\u2013T208. https:\/\/doi.org\/10.1530\/ERC-17-0243","journal-title":"Endocr Relat Cancer"},{"key":"9742_CR82","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"Thakker R V, Newey PJ, Walls G V, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML (2012) Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97:2990\u20133011. https:\/\/doi.org\/10.1210\/jc.2012-1230","journal-title":"J Clin Endocrinol Metab"},{"key":"9742_CR83","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000345670","volume":"41","author":"M Lee","year":"2013","unstructured":"Lee M, Pellegata NS (2013) Multiple endocrine neoplasia type 4. Front Horm Res 41:63\u201378. https:\/\/doi.org\/10.1159\/000345670","journal-title":"Front Horm Res"},{"key":"9742_CR84","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1210\/jc.2019-00082","volume":"104","author":"A Frederiksen","year":"2019","unstructured":"Frederiksen A, Rossing M, Hermann P, Ejersted C, Thakker R V, Frost M (2019) Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel Pathogenic Variant and Review of Published Cases. J Clin Endocrinol Metab 104:3637\u20133646. https:\/\/doi.org\/10.1210\/jc.2019-00082","journal-title":"J Clin Endocrinol Metab"},{"key":"9742_CR85","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1210\/clinem\/dgac162","volume":"107","author":"A Seabrook","year":"2022","unstructured":"Seabrook A, Wijewardene A, De Sousa S, Wong T, Sheriff N, Gill AJ, Iyer R, Field M, Luxford C, Clifton-Bligh R, McCormack A, Tucker K (2022) MEN4, the MEN1 Mimicker: A Case Series of three Phenotypically Heterogenous Patients With Unique CDKN1B Mutations. J Clin Endocrinol Metab 107:2339\u20132349. https:\/\/doi.org\/10.1210\/clinem\/dgac162","journal-title":"J Clin Endocrinol Metab"},{"key":"9742_CR86","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.beem.2010.01.001","volume":"24","author":"M Georgitsi","year":"2010","unstructured":"Georgitsi M (2010) MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations. Best Pract Res Clin Endocrinol Metab 24:425\u2013437. https:\/\/doi.org\/10.1016\/j.beem.2010.01.001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"9742_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.773143","volume":"13","author":"E Lavezzi","year":"2022","unstructured":"Lavezzi E, Brunetti A, Smiroldo V, Nappo G, Pedicini V, Vitali E, Trivellin G, Mazziotti G, Lania A (2022) Case Report: New CDKN1B Mutation in Multiple Endocrine Neoplasia Type 4 and Brief Literature Review on Clinical Management. Front Endocrinol 13:773143. https:\/\/doi.org\/10.3389\/fendo.2022.773143","journal-title":"Front Endocrinol"},{"key":"9742_CR88","unstructured":"Asa SL, Perren A, Osamura RY, Pellegata NS, Gimenez-Roqueplo A-P, Hern\u00e1ndez-Ram\u00edrez LC, Valk GD (2022) Multiple endocrine neoplasia type 4. In: Endocrine and Neuroendocrine tumours"},{"key":"9742_CR89","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1210\/clinem\/dgaa160","volume":"105","author":"F Chasseloup","year":"2020","unstructured":"Chasseloup F, Pankratz N, Lane J, Faucz FR, Keil MF, Chittiboina P, Kay DM, Hussein Tayeb T, Stratakis CA, Mills JL, Hern\u00e1ndez-Ram\u00edrez LC (2020) Germline CDKN1B Loss-of-Function Variants Cause Pediatric Cushing\u2019s Disease With or Without an MEN4 Phenotype. J Clin Endocrinol Metab 105:1983\u20132005. https:\/\/doi.org\/10.1210\/clinem\/dgaa160","journal-title":"J Clin Endocrinol Metab"},{"key":"9742_CR90","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1055\/a-0753-4943","volume":"127","author":"CDC Kamilaris","year":"2019","unstructured":"Kamilaris CDC, Faucz FR, Voutetakis A, Stratakis CA (2019) Carney Complex. Exp Clin Endocrinol Diabetes Off J Ger Soc Endocrinol Ger Diabetes Assoc 127:156\u2013164. https:\/\/doi.org\/10.1055\/a-0753-4943","journal-title":"Exp Clin Endocrinol Diabetes Off J Ger Soc Endocrinol Ger Diabetes Assoc"},{"key":"9742_CR91","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1172\/JCI118467","volume":"97","author":"CA Stratakis","year":"1996","unstructured":"Stratakis CA, Carney JA, Lin JP, Papanicolaou DA, Karl M, Kastner DL, Pras E, Chrousos GP (1996) Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest 97:699\u2013705. https:\/\/doi.org\/10.1172\/JCI118467","journal-title":"J Clin Invest"},{"key":"9742_CR92","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1056\/NEJMc1309730","volume":"370","author":"A Forlino","year":"2014","unstructured":"Forlino A, Vetro A, Garavelli L, Ciccone R, London E, Stratakis CA, Zuffardi O (2014) PRKACB and Carney complex. N. Engl. J. Med. 370:1065\u20131067","journal-title":"N. Engl. J. Med."},{"key":"9742_CR93","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1210\/jcem.86.9.7903","volume":"86","author":"CA Stratakis","year":"2001","unstructured":"Stratakis CA, Kirschner LS, Carney JA (2001) Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 86:4041\u20134046. https:\/\/doi.org\/10.1210\/jcem.86.9.7903","journal-title":"J Clin Endocrinol Metab"},{"key":"9742_CR94","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/79238","volume":"26","author":"LS Kirschner","year":"2000","unstructured":"Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS, Stratakis CA (2000) Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 26:89\u201392. https:\/\/doi.org\/10.1038\/79238","journal-title":"Nat Genet"},{"key":"9742_CR95","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1210\/jc.2008-2333","volume":"94","author":"J Bertherat","year":"2009","unstructured":"Bertherat J, Horvath A, Groussin L, Grabar S, Boikos S, Cazabat L, Libe R, Ren\u00e9-Corail F, Stergiopoulos S, Bourdeau I, Bei T, Clauser E, Calender A, Kirschner LS, Bertagna X, Carney JA, Stratakis CA (2009) Mutations in regulatory subunit type 1A of cyclic adenosine 5\u2019-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J Clin Endocrinol Metab 94:2085\u20132091. https:\/\/doi.org\/10.1210\/jc.2008-2333","journal-title":"J Clin Endocrinol Metab"},{"key":"9742_CR96","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11102-006-0266-1","volume":"9","author":"L Cazabat","year":"2006","unstructured":"Cazabat L, Ragazzon B, Groussin L, Bertherat J (2006) PRKAR1A mutations in primary pigmented nodular adrenocortical disease. Pituitary 9:211\u2013219. https:\/\/doi.org\/10.1007\/s11102-006-0266-1","journal-title":"Pituitary"},{"key":"9742_CR97","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mce.2010.04.027","volume":"326","author":"LS Kirschner","year":"2010","unstructured":"Kirschner LS (2010) PRKAR1A and the evolution of pituitary tumors. Mol Cell Endocrinol 326:3\u20137. https:\/\/doi.org\/10.1016\/j.mce.2010.04.027","journal-title":"Mol Cell Endocrinol"},{"key":"9742_CR98","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s13244-012-0208-6","volume":"4","author":"NA Courcoutsakis","year":"2013","unstructured":"Courcoutsakis NA, Tatsi C, Patronas NJ, Lee C-CR, Prassopoulos PK, Stratakis CA (2013) The complex of myxomas, spotty skin pigmentation and endocrine overactivity (Carney complex): imaging findings with clinical and pathological correlation. Insights Imaging 4:119\u2013133. https:\/\/doi.org\/10.1007\/s13244-012-0208-6","journal-title":"Insights Imaging"},{"key":"9742_CR99","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11102-006-0265-2","volume":"9","author":"SA Boikos","year":"2006","unstructured":"Boikos SA, Stratakis CA (2006) Pituitary pathology in patients with Carney Complex: growth-hormone producing hyperplasia or tumors and their association with other abnormalities. Pituitary 9:203\u2013209. https:\/\/doi.org\/10.1007\/s11102-006-0265-2","journal-title":"Pituitary"},{"key":"9742_CR100","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1227\/NEU.0000000000001384","volume":"80","author":"RR Lonser","year":"2017","unstructured":"Lonser RR, Mehta GU, Kindzelski BA, Ray-Chaudhury A, Vortmeyer AO, Dickerman R, Oldfield EH (2017) Surgical Management of Carney Complex-Associated Pituitary Pathology. Neurosurgery 80:780\u2013786. https:\/\/doi.org\/10.1227\/NEU.0000000000001384","journal-title":"Neurosurgery"},{"key":"9742_CR101","unstructured":"Kirschner LS, Stratakis CA, Mete O (2022) Carney Complex. In: Endocrine and Neuroendocrine Tumours"},{"key":"9742_CR102","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11102-005-5348-y","volume":"7","author":"SG Stergiopoulos","year":"2004","unstructured":"Stergiopoulos SG, Abu-Asab MS, Tsokos M, Stratakis CA (2004) Pituitary pathology in Carney complex patients. Pituitary 7:73\u201382. https:\/\/doi.org\/10.1007\/s11102-005-5348-y","journal-title":"Pituitary"},{"key":"9742_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10071377","author":"A Bogus\u0142awska","year":"2021","unstructured":"Bogus\u0142awska A, Korbonits M (2021) Genetics of Acromegaly and Gigantism. J Clin Med 10:. https:\/\/doi.org\/10.3390\/jcm10071377","journal-title":"J Clin Med"},{"key":"9742_CR104","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12022-021-09663-4","volume":"32","author":"SL Asa","year":"2021","unstructured":"Asa SL, Mete O, Ezzat S (2021) Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know? Endocr Pathol 32:3\u201316. https:\/\/doi.org\/10.1007\/s12022-021-09663-4","journal-title":"Endocr Pathol"},{"key":"9742_CR105","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/hmg\/ddg160","volume":"12","author":"A Robinson-White","year":"2003","unstructured":"Robinson-White A, Hundley TR, Shiferaw M, Bertherat J, Sandrini F, Stratakis CA (2003) Protein kinase-A activity in PRKAR1A-mutant cells, and regulation of mitogen-activated protein kinases ERK1\/2. Hum Mol Genet 12:1475\u20131484. https:\/\/doi.org\/10.1093\/hmg\/ddg160","journal-title":"Hum Mol Genet"},{"key":"9742_CR106","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature03126","volume":"433","author":"AE Chen","year":"2005","unstructured":"Chen AE, Ginty DD, Fan C-M (2005) Protein kinase A signalling via CREB controls myogenesis induced by Wnt proteins. Nature 433:317\u2013322. https:\/\/doi.org\/10.1038\/nature03126","journal-title":"Nature"},{"key":"9742_CR107","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1158\/1055-9965.EPI-16-0693","volume":"26","author":"AK Win","year":"2017","unstructured":"Win AK, Jenkins MA, Dowty JG, Antoniou AC, Lee A, Giles GG, Buchanan DD, Clendenning M, Rosty C, Ahnen DJ, Thibodeau SN, Casey G, Gallinger S, Le Marchand L, Haile RW, Potter JD, Zheng Y, Lindor NM, Newcomb PA, Hopper JL, MacInnis RJ (2017) Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 26:404\u2013412. https:\/\/doi.org\/10.1158\/1055-9965.EPI-16-0693","journal-title":"Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"key":"9742_CR108","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1056\/NEJMoa043146","volume":"352","author":"H Hampel","year":"2005","unstructured":"Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Nakagawa H, Sotamaa K, Prior TW, Westman J, Panescu J, Fix D, Lockman J, Comeras I, de la Chapelle A (2005) Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer). N Engl J Med 352:1851\u20131860. https:\/\/doi.org\/10.1056\/NEJMoa043146","journal-title":"N Engl J Med"},{"key":"9742_CR109","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.1210\/jc.2017-01401","volume":"102","author":"D Bengtsson","year":"2017","unstructured":"Bengtsson D, Joost P, Aravidis C, Askmalm Stenmark M, Backman A-S, Melin B, von Salom\u00e9 J, Zagoras T, Gebre-Medhin S, Burman P (2017) Corticotroph Pituitary Carcinoma in a Patient With Lynch Syndrome (LS) and Pituitary Tumors in a Nationwide LS Cohort. J Clin Endocrinol Metab 102:3928\u20133932. https:\/\/doi.org\/10.1210\/jc.2017-01401","journal-title":"J Clin Endocrinol Metab"},{"key":"9742_CR110","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.wneu.2019.08.180","volume":"132","author":"MR Voisin","year":"2019","unstructured":"Voisin MR, Almeida JP, Perez-Ordonez B, Zadeh G (2019) Recurrent Undifferentiated Carcinoma of the Sella in a Patient with Lynch Syndrome. World Neurosurg 132:219\u2013222. https:\/\/doi.org\/10.1016\/j.wneu.2019.08.180","journal-title":"World Neurosurg"},{"key":"9742_CR111","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cancergen.2021.03.008","volume":"256\u2013257","author":"PB Loughrey","year":"2021","unstructured":"Loughrey PB, Baker G, Herron B, Cooke S, Iacovazzo D, Lindsay JR, Korbonits M (2021) Invasive ACTH-producing pituitary gland neoplasm secondary to MSH2 mutation. Cancer Genet 256\u2013257:36\u201339. https:\/\/doi.org\/10.1016\/j.cancergen.2021.03.008","journal-title":"Cancer Genet"},{"key":"9742_CR112","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/gim.2018.28","volume":"20","author":"DR Stewart","year":"2018","unstructured":"Stewart DR, Korf BR, Nathanson KL, Stevenson DA, Yohay K (2018) Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med Off J Am Coll Med Genet 20:671\u2013682. https:\/\/doi.org\/10.1038\/gim.2018.28","journal-title":"Genet Med Off J Am Coll Med Genet"},{"key":"9742_CR113","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/00129492-200501000-00016","volume":"26","author":"DGR Evans","year":"2005","unstructured":"Evans DGR, Moran A, King A, Saeed S, Gurusinghe N, Ramsden R (2005) Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol 26:93\u201397. https:\/\/doi.org\/10.1097\/00129492-200501000-00016","journal-title":"Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol"},{"key":"9742_CR114","doi-asserted-by":"crossref","unstructured":"Messiaen LM, Callens T, Mortier G, Beysen D, Vandenbroucke I, Van Roy N, Speleman F, Paepe AD (2000) Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 15:541\u2013555.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/10862084\/","DOI":"10.1002\/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N"},{"key":"9742_CR115","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.mrrev.2008.06.001","volume":"659","author":"M Rosner","year":"2008","unstructured":"Rosner M, Hanneder M, Siegel N, Valli A, Fuchs C, Hengstschl\u00e4ger M (2008) The mTOR pathway and its role in human genetic diseases. Mutat Res 659:284\u2013292. https:\/\/doi.org\/10.1016\/j.mrrev.2008.06.001","journal-title":"Mutat Res"},{"key":"9742_CR116","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.mcna.2019.07.004","volume":"103","author":"KI Ly","year":"2019","unstructured":"Ly KI, Blakeley JO (2019) The Diagnosis and Management of Neurofibromatosis Type 1. Med Clin North Am 103:1035\u20131054. https:\/\/doi.org\/10.1016\/j.mcna.2019.07.004","journal-title":"Med Clin North Am"},{"key":"9742_CR117","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000369802","volume":"83","author":"C Bizzarri","year":"2015","unstructured":"Bizzarri C, Bottaro G (2015) Endocrine implications of neurofibromatosis 1 in childhood. Horm Res Paediatr 83:232\u2013241. https:\/\/doi.org\/10.1159\/000369802","journal-title":"Horm Res Paediatr"},{"key":"9742_CR118","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000458525","volume":"87","author":"I Sani","year":"2017","unstructured":"Sani I, Albanese A (2017) Endocrine Long-Term Follow-Up of Children with Neurofibromatosis Type 1 and Optic Pathway Glioma\u2029. Horm Res Paediatr 87:179\u2013188. https:\/\/doi.org\/10.1159\/000458525","journal-title":"Horm Res Paediatr"},{"key":"9742_CR119","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1002\/ajmg.a.38308","volume":"173","author":"P Cambiaso","year":"2017","unstructured":"Cambiaso P, Galassi S, Palmiero M, Mastronuzzi A, Del Bufalo F, Capolino R, Cacchione A, Buonuomo PS, Gonfiantini M V, Bartuli A, Cappa M, Macchiaiolo M (2017) Growth hormone excess in children with neurofibromatosis type-1 and optic glioma. Am J Med Genet A 173:2353\u20132358. https:\/\/doi.org\/10.1002\/ajmg.a.38308","journal-title":"Am J Med Genet A"},{"key":"9742_CR120","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JME-14-0034","volume":"53","author":"T Eigler","year":"2014","unstructured":"Eigler T, Ben-Shlomo A (2014) Somatostatin system: molecular mechanisms regulating anterior pituitary hormones. J Mol Endocrinol 53:R1-19. https:\/\/doi.org\/10.1530\/JME-14-0034","journal-title":"J Mol Endocrinol"},{"key":"9742_CR121","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3171\/jns.1994.81.4.0595","volume":"81","author":"TJ Manski","year":"1994","unstructured":"Manski TJ, Haworth CS, Duval-Arnould BJ, Rushing EJ (1994) Optic pathway glioma infiltrating into somatostatinergic pathways in a young boy with gigantism. Case report. J Neurosurg 81:595\u2013600. https:\/\/doi.org\/10.3171\/jns.1994.81.4.0595","journal-title":"Case report. J Neurosurg"},{"key":"9742_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11082168","author":"F Hannah-Shmouni","year":"2022","unstructured":"Hannah-Shmouni F, Trivellin G, Beckers P, Karaviti LP, Lodish M, Tatsi C, Adesina AM, Adamidou F, Mintziori G, Josefson JL, Quezado M, Stratakis CA (2022) Neurofibromatosis Type 1 Has a Wide Spectrum of Growth Hormone Excess. J Clin Med 11:. https:\/\/doi.org\/10.3390\/jcm11082168","journal-title":"J Clin Med"},{"key":"9742_CR123","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/00000478-198605000-00007","volume":"10","author":"Y Dayal","year":"1986","unstructured":"Dayal Y, Tallberg KA, Nunnemacher G, DeLellis RA, Wolfe HJ (1986) Duodenal carcinoids in patients with and without neurofibromatosis. A comparative study. Am J Surg Pathol 10:348\u2013357. https:\/\/doi.org\/10.1097\/00000478-198605000-00007","journal-title":"Am J Surg Pathol"},{"key":"9742_CR124","first-page":"19","volume":"29","author":"C Cappelli","year":"2004","unstructured":"Cappelli C, Agosti B, Braga M, Cumetti D, Gandossi E, Rizzoni D, Agabiti Rosei E (2004) Von Recklinghausen\u2019s neurofibromatosis associated with duodenal somatostatinoma. A case report and review of the literature. Minerva Endocrinol 29:19\u201324","journal-title":"Minerva Endocrinol"},{"key":"9742_CR125","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1749-6632.2009.05117.x","volume":"1184","author":"KA Orlova","year":"2010","unstructured":"Orlova KA, Crino PB (2010) The tuberous sclerosis complex. Ann N Y Acad Sci 1184:87\u2013105. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.05117.x","journal-title":"Ann N Y Acad Sci"},{"key":"9742_CR126","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/j.1365-2265.2005.02374.x","volume":"63","author":"S Tigas","year":"2005","unstructured":"Tigas S, Carroll PV, Jones R, Bingham E, Russell-Jones D, Powell M, Scobie IN (2005) Simultaneous Cushing\u2019s disease and tuberous sclerosis; a potential role for TSC in pituitary ontogeny. Clin Endocrinol (Oxf) 63:694\u2013695. https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02374.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9742_CR127","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/j.1365-2265.2007.02941.x","volume":"67","author":"R Nandagopal","year":"2007","unstructured":"Nandagopal R, Vortmeyer A, Oldfield EH, Keil MF, Stratakis CA (2007) Cushing\u2019s syndrome due to a pituitary corticotropinoma in a child with tuberous sclerosis: an association or a coincidence? Clin Endocrinol (Oxf) 67:639\u2013641. https:\/\/doi.org\/10.1111\/j.1365-2265.2007.02941.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9742_CR128","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1677\/ERC-08-0142","volume":"16","author":"D Dworakowska","year":"2009","unstructured":"Dworakowska D, Grossman AB (2009) Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review. Endocr Relat Cancer 16:45\u201358. https:\/\/doi.org\/10.1677\/ERC-08-0142","journal-title":"Endocr Relat Cancer"},{"key":"9742_CR129","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-18-0086","author":"D Regazzo","year":"2018","unstructured":"Regazzo D, Gardiman MP, Theodoropoulou M, Scaroni C, Occhi G, Ceccato F (2018) Silent gonadotroph pituitary neuroendocrine tumor in a patient with tuberous sclerosis complex: evaluation of a possible molecular link. Endocrinol Diabetes Metab Case Rep 2018:. https:\/\/doi.org\/10.1530\/EDM-18-0086","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"9742_CR130","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1002\/ajmg.a.62850","volume":"188","author":"LM Evans","year":"2022","unstructured":"Evans LM, Geenen KR, O\u2019Shea A, Hedgire SS, Ferrone CR, Thiele EA (2022) Tuberous sclerosis complex-associated nonfunctional pancreatic neuroendocrine tumors: Management and surgical outcomes. Am J Med Genet A 188:2666\u20132671. https:\/\/doi.org\/10.1002\/ajmg.a.62850","journal-title":"Am J Med Genet A"},{"key":"9742_CR131","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00247-016-3701-0","volume":"47","author":"G Koc","year":"2017","unstructured":"Koc G, Sugimoto S, Kuperman R, Kammen BF, Karakas SP (2017) Pancreatic tumors in children and young adults with tuberous sclerosis complex. Pediatr Radiol 47:39\u201345. https:\/\/doi.org\/10.1007\/s00247-016-3701-0","journal-title":"Pediatr Radiol"},{"key":"9742_CR132","doi-asserted-by":"publisher","unstructured":"Al Qahtani MS, Bojal SA, Alqarzaie AA, Alqahtani AA (2021) Insulinoma in tuberous sclerosis: An entity not to be missed. Saudi Med J 42:332\u2013337. https:\/\/doi.org\/10.15537\/smj.2021.42.3.20200490","DOI":"10.15537\/smj.2021.42.3.20200490"},{"key":"9742_CR133","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.1158\/1078-0432.CCR-16-0452","volume":"22","author":"F Caimari","year":"2016","unstructured":"Caimari F, Korbonits M (2016) Novel Genetic Causes of Pituitary Adenomas. Clin Cancer Res Off J Am Assoc Cancer Res 22:5030\u20135042. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0452","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"9742_CR134","doi-asserted-by":"publisher","first-page":"E710","DOI":"10.1210\/jc.2014-4297","volume":"100","author":"P Xekouki","year":"2015","unstructured":"Xekouki P, Szarek E, Bullova P, Giubellino A, Quezado M, Mastroyannis SA, Mastorakos P, Wassif CA, Raygada M, Rentia N, Dye L, Cougnoux A, Koziol D, Sierra M de LL, Lyssikatos C, Belyavskaya E, Malchoff C, Moline J, Eng C, Maher LJ 3rd, Pacak K, Lodish M, Stratakis CA (2015) Pituitary adenoma with paraganglioma\/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice. J Clin Endocrinol Metab 100:E710-719. https:\/\/doi.org\/10.1210\/jc.2014-4297","journal-title":"J Clin Endocrinol Metab"},{"key":"9742_CR135","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1530\/EJE-20-0054","volume":"183","author":"G Mougel","year":"2020","unstructured":"Mougel G, Lagarde A, Albarel F, Essamet W, Luigi P, Mouly C, Vialon M, Cuny T, Castinetti F, Saveanu A, Brue T, Barlier A, Romanet P (2020) Germinal defects of SDHx genes in patients with isolated pituitary adenoma. Eur J Endocrinol 183:369\u2013379. https:\/\/doi.org\/10.1530\/EJE-20-0054","journal-title":"Eur J Endocrinol"},{"key":"9742_CR136","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1210\/clinem\/dgaa957","volume":"106","author":"AJ Seabrook","year":"2021","unstructured":"Seabrook AJ, Harris JE, Velosa SB, Kim E, McInerney-Leo AM, Dwight T, Hockings JI, Hockings NG, Kirk J, Leo PJ, Love AJ, Luxford C, Marshall M, Mete O, Pennisi DJ, Brown MA, Gill AJ, Hockings GI, Clifton-Bligh RJ, Duncan EL (2021) Multiple Endocrine Tumors Associated with Germline MAX Mutations: Multiple Endocrine Neoplasia Type 5? J Clin Endocrinol Metab 106:1163\u20131182. https:\/\/doi.org\/10.1210\/clinem\/dgaa957","journal-title":"J Clin Endocrinol Metab"},{"key":"9742_CR137","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3389\/fendo.2020.00234","volume":"11","author":"C Pozza","year":"2020","unstructured":"Pozza C, Sesti F, Di Dato C, Sbardella E, Pofi R, Schiavi F, Bonifacio V, Isidori AM, Faggiano A, Lenzi A, Giannetta E (2020) A Novel MAX Gene Mutation Variant in a Patient With Multiple and \u201cComposite\u201d Neuroendocrine-Neuroblastic Tumors. Front Endocrinol 11:234. https:\/\/doi.org\/10.3389\/fendo.2020.00234","journal-title":"Front Endocrinol"},{"key":"9742_CR138","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1210\/jc.2017-02324","volume":"103","author":"D Ta\u00efeb","year":"2018","unstructured":"Ta\u00efeb D, Jha A, Guerin C, Pang Y, Adams KT, Chen CC, Romanet P, Roche P, Essamet W, Ling A, Quezado MM, Castinetti F, Sebag F, Pacak K (2018) 18F-FDOPA PET\/CT Imaging of MAX-Related Pheochromocytoma. J Clin Endocrinol Metab 103:1574\u20131582. https:\/\/doi.org\/10.1210\/jc.2017-02324","journal-title":"J Clin Endocrinol Metab"},{"key":"9742_CR139","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-12-0160","volume":"18","author":"N Burnichon","year":"2012","unstructured":"Burnichon N, Casc\u00f3n A, Schiavi F, Morales NP, Comino-M\u00e9ndez I, Abermil N, Inglada-P\u00e9rez L, de Cubas AA, Amar L, Barontini M, de Quir\u00f3s SB, Bertherat J, Bignon Y-J, Blok MJ, Bobisse S, Borrego S, Castellano M, Chanson P, Chiara M-D, Corssmit EPM, Giacch\u00e8 M, de Krijger RR, Ercolino T, Girerd X, G\u00f3mez-Garc\u00eda EB, G\u00f3mez-Gra\u00f1a \u00c1, Guilhem I, Hes FJ, Honrado E, Korpershoek E, Lenders JWM, Let\u00f3n R, Mensenkamp AR, Merlo A, Mori L, Murat A, Pierre P, Plouin P-F, Prodanov T, Quesada-Charneco M, Qin N, Rapizzi E, Raymond V, Reisch N, Roncador G, Ruiz-Ferrer M, Schillo F, Stegmann APA, Suarez C, Taschin E, Timmers HJLM, Tops CMJ, Urioste M, Beuschlein F, Pacak K, Mannelli M, Dahia PLM, Opocher G, Eisenhofer G, Gimenez-Roqueplo A-P, Robledo M (2012) MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma. Clin Cancer Res 18:2828\u20132837. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0160","journal-title":"Clin Cancer Res"},{"key":"9742_CR140","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1001\/jamaoncol.2017.0223","volume":"3","author":"B Bausch","year":"2017","unstructured":"Bausch B, Schiavi F, Ni Y, Welander J, Patocs A, Ngeow J, Wellner U, Malinoc A, Taschin E, Barbon G, Lanza V, S\u00f6derkvist P, Stenman A, Larsson C, Svahn F, Chen J-L, Marquard J, Fraenkel M, Walter MA, Peczkowska M, Prejbisz A, Jarzab B, Hasse-Lazar K, Petersenn S, Moeller LC, Meyer A, Reisch N, Trupka A, Brase C, Galiano M, Preuss SF, Kwok P, Lendvai N, Berisha G, Makay \u00d6, Boedeker CC, Weryha G, Racz K, Januszewicz A, Walz MK, Gimm O, Opocher G, Eng C, Neumann HPH, for the European-American-Asian Pheochromocytoma-Paraganglioma Registry Study Group (2017) Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention. JAMA Oncol 3:1204\u20131212. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0223","journal-title":"JAMA Oncol"},{"key":"9742_CR141","doi-asserted-by":"crossref","unstructured":"Ferrara AM, Lombardi G, Pambuku A, Meringolo D, Bertorelle R, Nardin M, Schiavi F, Iacobone M, Opocher G, Zagonel V, Zovato S (2018) Temozolomide treatment of a malignant pheochromocytoma and an unresectable MAX-related paraganglioma. Anticancer Drugs 29:","DOI":"10.1097\/CAD.0000000000000570"},{"key":"9742_CR142","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s40792-017-0408-x","volume":"3","author":"M Shibata","year":"2017","unstructured":"Shibata M, Inaishi T, Miyajima N, Adachi Y, Takano Y, Nakanishi K, Takeuchi D, Noda S, Aita Y, Takekoshi K, Kodera Y, Kikumori T (2017) Synchronous bilateral pheochromocytomas and paraganglioma with novel germline mutation in MAX: a case report. Surg Case Rep 3:131. https:\/\/doi.org\/10.1186\/s40792-017-0408-x","journal-title":"Surg Case Rep"},{"key":"9742_CR143","doi-asserted-by":"publisher","unstructured":"Gonz\u00e1lez IA, Stewart DR, Schultz KAP, Field AP, Hill DA, Dehner LP (2022) DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma. Mod Pathol Off J U S Can Acad Pathol Inc 35:4\u201322. https:\/\/doi.org\/10.1038\/s41379-021-00905-8","DOI":"10.1038\/s41379-021-00905-8"},{"key":"9742_CR144","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1002\/ijc.30907","volume":"141","author":"J Kim","year":"2017","unstructured":"Kim J, Field A, Schultz KAP, Hill DA, Stewart DR (2017) The prevalence of DICER1 pathogenic variation in population databases. Int J Cancer 141:2030\u20132036. https:\/\/doi.org\/10.1002\/ijc.30907","journal-title":"Int J Cancer"},{"key":"9742_CR145","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-014-1285-z","volume":"128","author":"L de Kock","year":"2014","unstructured":"de Kock L, Sabbaghian N, Plourde F, Srivastava A, Weber E, Bouron-Dal Soglio D, Hamel N, Choi JH, Park S-H, Deal CL, Kelsey MM, Dishop MK, Esbenshade A, Kuttesch JF, Jacques TS, Perry A, Leichter H, Maeder P, Brundler M-A, Warner J, Neal J, Zacharin M, Korbonits M, Cole T, Traunecker H, McLean TW, Rotondo F, Lepage P, Albrecht S, Horvath E, Kovacs K, Priest JR, Foulkes WD (2014) Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations. Acta Neuropathol (Berl) 128:111\u2013122. https:\/\/doi.org\/10.1007\/s00401-014-1285-z","journal-title":"Acta Neuropathol (Berl)"},{"key":"9742_CR146","doi-asserted-by":"publisher","first-page":"E1487","DOI":"10.1210\/jc.2014-1016","volume":"99","author":"T Sahakitrungruang","year":"2014","unstructured":"Sahakitrungruang T, Srichomthong C, Pornkunwilai S, Amornfa J, Shuangshoti S, Kulawonganunchai S, Suphapeetiporn K, Shotelersuk V (2014) Germline and somatic DICER1 mutations in a pituitary blastoma causing infantile-onset Cushing\u2019s disease. J Clin Endocrinol Metab 99:E1487-92. https:\/\/doi.org\/10.1210\/jc.2014-1016","journal-title":"J Clin Endocrinol Metab"},{"key":"9742_CR147","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11102-011-0328-x","volume":"15","author":"BW Scheithauer","year":"2012","unstructured":"Scheithauer BW, Horvath E, Abel TW, Robital Y, Park S-H, Osamura RY, Deal C, Lloyd R V, Kovacs K (2012) Pituitary blastoma: a unique embryonal tumor. Pituitary 15:365\u2013373. https:\/\/doi.org\/10.1007\/s11102-011-0328-x","journal-title":"Pituitary"},{"key":"9742_CR148","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-18-0087","author":"E Cotton","year":"2018","unstructured":"Cotton E, Ray D (2018) DICER1 mutation and pituitary prolactinoma. Endocrinol Diabetes Metab Case Rep 2018:. https:\/\/doi.org\/10.1530\/EDM-18-0087","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"9742_CR149","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1158\/1078-0432.CCR-17-3089","volume":"24","author":"KAP Schultz","year":"2018","unstructured":"Schultz KAP, Williams GM, Kamihara J, Stewart DR, Harris AK, Bauer AJ, Turner J, Shah R, Schneider K, Schneider KW, Carr AG, Harney LA, Baldinger S, Frazier AL, Orbach D, Schneider DT, Malkin D, Dehner LP, Messinger YH, Hill DA (2018) DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies. Clin Cancer Res Off J Am Assoc Cancer Res 24:2251\u20132261. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-3089","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"9742_CR150","doi-asserted-by":"publisher","first-page":"34718","DOI":"10.1074\/jbc.M110.126441","volume":"285","author":"Z Zhang","year":"2010","unstructured":"Zhang Z, Florez S, Gutierrez-Hartmann A, Martin JF, Amendt BA (2010) MicroRNAs regulate pituitary development, and microRNA 26b specifically targets lymphoid enhancer factor 1 (Lef-1), which modulates pituitary transcription factor 1 (Pit-1) expression. J Biol Chem 285:34718\u201334728. https:\/\/doi.org\/10.1074\/jbc.M110.126441","journal-title":"J Biol Chem"},{"key":"9742_CR151","doi-asserted-by":"publisher","DOI":"10.1101\/005686","author":"B Arman Aksoy","year":"2014","unstructured":"Arman Aksoy B, Jacobsen A, Fieldhouse RJ, Lee W, Demir E, Ciriello G, Schultz N, Marks DS, Sander C (2014) Cancer-associated recurrent mutations in RNase III domains of DICER1. bioRxiv 5686. https:\/\/doi.org\/10.1101\/005686","journal-title":"bioRxiv"},{"key":"9742_CR152","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/cen.14706","volume":"97","author":"EC Coopmans","year":"2022","unstructured":"Coopmans EC, Korbonits M (2022) Molecular genetic testing in the management of pituitary disease. Clin Endocrinol (Oxf) 97:424\u2013435. https:\/\/doi.org\/10.1111\/cen.14706","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9742_CR153","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s12020-021-02633-0","volume":"71","author":"J D\u00e9nes","year":"2021","unstructured":"D\u00e9nes J, Korbonits M (2021) The clinical aspects of pituitary tumour genetics. Endocrine 71:663\u2013674. https:\/\/doi.org\/10.1007\/s12020-021-02633-0","journal-title":"Endocrine"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-022-09742-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-022-09742-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-022-09742-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T08:34:58Z","timestamp":1678696498000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-022-09742-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":153,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["9742"],"URL":"https:\/\/doi.org\/10.1007\/s12022-022-09742-0","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,18]]},"assertion":[{"value":"10 November 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}